Health Risks of Cigar Smoking and Cessation Approach
Cigar smoking poses significant cardiovascular and respiratory risks comparable to cigarettes, including increased mortality, coronary heart disease, stroke, COPD, and lung cancer—cessation should follow the same evidence-based approach as cigarette smoking using combination pharmacotherapy (nicotine replacement therapy or varenicline) plus behavioral counseling. 1, 2, 3
Detrimental Health Effects of Cigars
Cardiovascular Risks
- Coronary heart disease events occur with cigar use, though to a slightly lesser degree than cigarette smoking 1
- Meta-analyses demonstrate increased CHD risk with smokeless tobacco and cigar use 1
- Switching from cigarettes to pipes or cigars confers little to no benefit—a British Regional Heart Study found pipe/cigar switchers had a 3.3-fold increased stroke risk, similar to light cigarette smokers 4
- Cigar smoking adversely affects endothelial function, promotes atherosclerosis, and is prothrombotic 1
Respiratory and Mortality Risks
- Exclusive pipe/cigar users without cigarette history show accelerated lung function decline: 3.36 mL/year faster FEV1 decline and 3.73 mL/year faster FVC decline compared to never-tobacco users 5
- All-cause mortality increases by 24% (HR 1.24) among exclusive cigar users 5
- COPD hospitalization/mortality risk doubles (HR 2.02) in cigar-only smokers 5
- Preserved ratio impaired spirometry risk increases 83% (HR 1.83) 5
Cancer Risks
- All combustible tobacco products, including cigars, hookah, and pipes, cause at least 30% of all cancer deaths 2
- Cigars pose similar health risks to cigarettes for malignancies 6
Critical Misconception
A dangerous knowledge gap exists: Many cigar smokers, particularly young adults using cigarillos and blunts, do not believe cigar smoking is risky behavior and show uncertainty about product harms and addictiveness relative to cigarettes 7, 8, 9. This is especially problematic in Black young adult populations who have high cigar prevalence but receive minimal cessation assistance from healthcare providers 8.
Recommended Cessation Approach
Systematic Screening and Assessment
- Screen ALL patients for tobacco use at every clinical encounter, including specific assessment for cigars, pipes, hookah, and smokeless tobacco—not just cigarettes 1, 2
- Document smoking status in the health record and update at regular intervals 2
- Assess nicotine dependency: amount smoked daily, time to first use after waking, use of other tobacco/nicotine products 2
- Evaluate quit history: longest abstinence period, previous quit attempts, methods used, reasons for failure 2
Evidence-Based Cessation Strategy
The most effective approach combines pharmacotherapy with behavioral therapy 2, 10—this is not optional but the standard of care.
Preferred Primary Pharmacotherapy Options:
- Combination NRT (long-acting patch PLUS short-acting form for breakthrough cravings—gum, lozenge, inhaler, or nasal spray) 2
- Varenicline (12-week initial course) 2, 10, 2
Try both preferred options before considering alternatives 2. Bupropion is a secondary option 10.
Behavioral Therapy Requirements:
- High-intensity counseling with multiple sessions is most effective, but minimum brief counseling is mandatory 2
- Utilize telephone quitlines (1-800-QUIT-NOW), web-based programs (Freedom From Smoking, Smokefree.gov), or in-person counseling 1
- Behavioral resources should be provided at every pharmacotherapy initiation 2
Follow-Up Protocol
- Initial follow-up within 2-3 weeks of starting therapy to assess efficacy, toxicity, and withdrawal symptoms 2
- Continue periodic assessment at no more than 12-week intervals 2
- Assess adherence, adjust doses as needed, and address side effects 2
- Relapse is expected and normal—smoking slips do not necessarily indicate need for alternative methods; multiple quit attempts with the same therapy may be required 2
Special Considerations
Surgical Patients:
- Cessation should occur as far in advance of surgery as feasible 2
- Do NOT delay appropriate cancer surgery based on smoking status 2
- NRT at normal doses does not negatively affect acute wound healing 2
Contraindications:
- Avoid varenicline and bupropion in patients with brain metastases (increased seizure risk) 2
- Manage nausea from varenicline in patients receiving chemotherapy 2
Healthcare Provider Responsibilities
A critical gap exists: Most healthcare providers do not screen for cigar use specifically, and even when aware, provide little cessation assistance 8. This must change.
- Deliver clear, strong, personalized advice: "Cigar smoking increases your risk of heart attack, stroke, and lung disease. Quitting is the single most important thing you can do to protect your health" 3
- Prescribe approved medications (combination NRT, varenicline, bupropion, or cytisine where available) 11
- Refer to specialized smoking cessation clinics for patients who fail brief interventions 12
Benefits of Cessation
- Smoking cessation after MI reduces mortality by 36% and MI recurrence by 32% 1
- Stroke risk in light cigar smokers returns to never-smoker levels within 5 years of complete cessation 4
- Benefits occur at any age—it is never too late to quit, even for patients with advanced disease or end-of-life care 2
Common Pitfall to Avoid
Switching from cigarettes to cigars or pipes is NOT harm reduction—the cardiovascular and respiratory risks remain substantially elevated 4. Complete cessation of all combustible tobacco is required 2, 3.